Literature DB >> 15193279

Hepatocyte growth factor disrupts tight junctions in human breast cancer cells.

Tracey A Martin1, Gareth Watkins, Robert E Mansel, Wen G Jiang.   

Abstract

Tight junctions in epithelial cells act as cell-cell adhesion structures and govern paracellular permeability. Disruption of these functions can lead to dissociation of cancer cells. This study aimed to determine whether HGF, a cytokine secreted by stromal cells, is capable of modulating expression and function of tight junction molecules in human breast cancer cell lines. HGF decreased trans-epithelial resistance and increased paracellular permeability of two human breast cancer cell lines, MDA MB 231 and MCF-7. Q-PCR showed that HGF modulated the levels of several tight junction molecule (occludin, claudin-1 and -5, JAM-1 and -2) mRNA transcripts in MDA MB 231 and MCF-7 cells. Western blotting and immunohistochemistry also showed modulation of expression of the tight junction molecule, occludin. It is suggested that HGF disrupts tight junction function in human breast cancer cells by effecting changes in the expression of tight junction molecules at both the mRNA and protein levels. We conclude that regulation of tight junctions could be of fundamental importance in the prevention of metastasis of breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193279     DOI: 10.1016/j.cellbi.2004.03.003

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  10 in total

Review 1.  Regulation of cell junction dynamics by cytokines in the testis: a molecular and biochemical perspective.

Authors:  Wing-Yee Lui; C Yan Cheng
Journal:  Cytokine Growth Factor Rev       Date:  2007-05-22       Impact factor: 7.638

2.  Hepatocyte growth factor system in the mouse uterus: variation across the estrous cycle and regulation by 17-beta-estradiol and progesterone.

Authors:  Xuan Zhang
Journal:  Biol Reprod       Date:  2010-02-10       Impact factor: 4.285

Review 3.  Therapeutic Strategies for Ovarian Cancer in Point of HGF/c-MET Targeting.

Authors:  Hyun Jung Kim
Journal:  Medicina (Kaunas)       Date:  2022-05-11       Impact factor: 2.948

4.  Helicobacter pylori isolated from a patient with Ménétrier's disease increases hepatocyte growth factor mRNA expression in gastric fibroblasts: comparison with Helicobacter pylori isolated from other gastric diseases.

Authors:  Takeshi Ishikawa; Takashi Ando; Hiroshi Obayashi; Nami Nakabe; Mika Okita; Yutaka Isozaki; Yasuyuki Nagao; Hirokazu Oyamada; Yoshihiro Nakajima; Haruki Kato; Satoshi Kokura; Yuji Naito; Norimasa Yoshida; Toshikazu Yoshikawa
Journal:  Dig Dis Sci       Date:  2007-11-08       Impact factor: 3.199

5.  Claudin family of proteins and cancer: an overview.

Authors:  Amar B Singh; Ashok Sharma; Punita Dhawan
Journal:  J Oncol       Date:  2010-07-08       Impact factor: 4.375

6.  Putting the brakes on cancer cell migration: JAM-A restrains integrin activation.

Authors:  Ulhas P Naik; Meghna U Naik
Journal:  Cell Adh Migr       Date:  2008-10-06       Impact factor: 3.405

7.  Hepatocyte growth factor regulates the development of highly pure cultured chief cells from rat stomach by stimulating chief cell proliferation in vitro.

Authors:  Kimihito Tashima; Songhua Zhang; Regina Ragasa; Eiji Nakamura; Ji Hye Seo; Asli Muvaffak; Susan J Hagen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-20       Impact factor: 4.052

8.  Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways.

Authors:  Astrid Escudero-Esparza; Wen G Jiang; Tracey A Martin
Journal:  J Exp Clin Cancer Res       Date:  2012-05-04

9.  The expression of the Nectin complex in human breast cancer and the role of Nectin-3 in the control of tight junctions during metastasis.

Authors:  Tracey A Martin; Jane Lane; Gregory M Harrison; Wen G Jiang
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

Review 10.  HGF/Met Signaling in Cancer Invasion: The Impact on Cytoskeleton Remodeling.

Authors:  Chuan Xiang; Junxia Chen; Panfeng Fu
Journal:  Cancers (Basel)       Date:  2017-05-05       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.